Electrical nose could sniff out cancer

By Kayleigh Shooter
Share
It has recently been discovered that an electrical nose can aid the detection of cancer, we take a look at how this is possible...

 An electronic device has been developed by scientists, it is able to “sniff” breath and identify people with a certain condition that may lead to oesophagus cancer. Recent studies conducted show that there are approximately 9,000 new cases of oesophageal cancer, every year in the UK alone, this innovative technology could help to identify these cases earlier and therefore treat the cancer earlier. 

It has been found, by Cancer Research UK, that people diagnosed with Barrett’s oesophagus (the precancerous condition that is detected by the electronic nose) are at 11 times greater risk of developing oesophageal adenocarcinoma. The condition presents no symptoms however it tends to be more common among people with long-term acid reflux problems.

Currently, with limited access to such innovative technology, diagnoses is conducted through on endoscopy which is an expensive and an invasive technique, whereas the electronic nose will be far from invasive, making the experience as least traumatic as it can be. The improved experience is hoped to encourage more people to have a screening, this will decrease the number of cancer cases and ease pressure on the healthcare system. 

Prof Peter Siersema, co-author of the research from the Radboud Institute for Health Sciences in the Netherlands on the new detection method' “If you have a test available that is non-invasive and easily [detects] patients at risk of developing oesophageal cancer, then, of course, the participation rates will be much higher as compared to using upper endoscopy”

The innovative electronic nose uses a certain type of artificial intelligence to identify a particular component in a sample of breath. When trailed, the nose had correctly identified patients with the condition 91% of the time, and it correctly identified those without the condition just less than three-quarters of the time.
The team developing the tool plan to repeat the experiment in a sample group of 1,000 members, which they expect will lead to an increase in the system’s accuracy. If the trails go well the innovative device is hoped to be available to GP practices in two to three years time. 

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma